Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q1 EPS of ($1.76), $0.33 worse than the analyst estimate of ($1.43).

For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.